Sangamo Therapeutics
SGMO
#6363
Rank
โ‚ฌ0.55 B
Marketcap
2,68ย โ‚ฌ
Share price
2.14%
Change (1 day)
855.54%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚ฌ27.12 Million

According to Sangamo Therapeutics 's latest financial reports the company's total debt is โ‚ฌ27.12 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Sangamo Therapeutics - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ34.46 M-14.23%
2022-12-31โ‚ฌ40.18 M-5.34%
2021-12-31โ‚ฌ42.45 M24.08%
2020-12-31โ‚ฌ34.21 M-13.68%
2019-12-31โ‚ฌ39.64 M63.78%
2018-12-31โ‚ฌ24.2 M17.39%
2017-12-31โ‚ฌ20.61 M449.72%
2016-12-31โ‚ฌ3.75 M
2015-12-31N/A
2001-12-31โ‚ฌ0.32 M
1999-12-31โ‚ฌ0.29 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ21.76 B 80,148.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.21 B 4,374.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.30 B 207,474.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.20 B 22,787.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ16.69 B 61,452.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ33.32 B 122,768.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.56 B 1,971.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ35.22 B 129,769.06%๐Ÿ‡บ๐Ÿ‡ธ USA